Week 2 Peds Therapeutics Flashcards
most common organism in <1 month with bacterial meningitis
Group B Strep
most common organism in 1-23 months with bacterial meningitis
S. pneumoniae and neisseria meningitidis
most common organism in 2-50 yovwith bacterial meningitis
N. meningitidis
risk factors for bacterial meningitis in children
HIV
Immunodeficiency
Sickle cell anemia
Recent upper resp tract inf
Head Trauma
Presentation of bacterial meningitis
Infants
-Seizures, Irritability, Lethargy, Bulging fontanelle
Children
-Fever, Vomiting, Seizure, Confusion, Photophobia
Gold Standard for Bacterial Meningitis Diagnosis
CSF lumbar puncture
- elevated WBC, Protein, Glu (low in infants <0.6), pos bacterial culture
Empiric Treatment for neonates with BM
Ampilicillin + (AG or Cefotaxime)
Cefotaxime preferred if pt has poor kidney function
Empiric Treatment for 1 mon-50 yo with BM
Vancomycin + (Cefotaxime or CTX)
Targeted Treatment for infants with BM
Penicillin or Ampicillin
3rd gen cephalo
Duration of therapy for N. meningitidis & H. influenza
7 days
Days of treatment for S. Pneumoniae
10-14 days
Use and admin of dexamethasone as adj therapy in BM
- dec hearing loos in pts w/ H. influenza
- Only use before or at the same time as 1st dose of AB. after 1 hr post AB no benefit
- use with S. Pneumonia if risk of mortality
- use with H. influenza if initiated b/f admin of AB
Prevention of BM
Vaccines
- Hib, PCV15/PCV20, Meningococcal
Risk factors for CAP (5)
- Recent hx of URTI
- lower socioeconomic status
- Crowded living environment
- Exposure to cigarette smoke
- Comorbidities
What comorbidities are associated with CAP
Asthma
Bronchospasm
Cystic fibrosis
Congenital heart disease
Sickle cell disease
ways pathogen enters the lung and most common
**inhaled aerosolized particles
- through bloodstream
- aspiration
signs and symptoms of CAP and the ones required for diagnosis
**fever and cough
- chest pain
- purulent expectorant
- tachypnea (inf >70, child >50)
- respiratory distress
gold standard for diagnosis of CAP
chest x-ray
- viral will be wide spread
- bacteria will have dense consolidation
(6) who should be hospitalized for CAP
- mod to severe cap
- resp distress <90% sat
- all infants <3 months of age
- infants <6 months of age w/ suspected bacterial CAP
- suspicion of MRSA
- underlying medical conditions
most common bacterial pathogen of CAP in all age groups
S. pneumoniae
*Atypical common in older children
most common viral pathogen of CAP
Influenza
2nd most common bacterial pathogen of CAP in 5yo- 15yo group
Atypicals M & C. Pneumoniae
outpt first line treatment for CAP
Amox 90mg/kg/day in 2-3 doses
alt Augmentin 90mg/kg/day in 2-3 doses AE: diarrhea
inpt first line treatment for CAP who is fully immunized and low community resistance
Ampicillin or peni
Ampicillin empiric dose CAP
150-200 mg/kg/day IV divided every 6 hours
Ampicillin empiric dose for group A strep CAP
200 mg/kg/day IV divided every 6 hours
Ampicillin empiric dose for S. Pneumoniae
300-400 mg/kg/day IV divided every 6 hours CAP